Interferon gamma in autoimmune thyroiditis & thyroid function
干扰素γ在自身免疫性甲状腺炎中的作用
基本信息
- 批准号:7265107
- 负责人:
- 金额:$ 27.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-04-01 至 2008-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdipocytesApoptosisAppearanceAskenazy CellsAutoimmune DiseasesAutoimmune ProcessAutoimmune thyroiditisAutoimmunityCellsCessation of lifeCoculture TechniquesConflict (Psychology)DiseaseEpitheliumFatty acid glycerol estersGene ExpressionGeneticGrantGrowthHashimoto DiseaseHistocompatibility Antigens Class IIHumanHypothyroidismIRF1 geneIn SituIncidenceIntercellular Adhesion MoleculesIntercellular adhesion molecule 1Interferon Type IIInterleukin-12Knockout MiceLeptinLesionLinkLymphocyteMediatingMonitorMorphologyMusNatureNumbersPathogenesisPatientsPhenotypeResearch PersonnelRoleSeveritiesSignal TransductionT-LymphocyteTestingThyroid Function TestsThyroid GlandThyroiditisThyrotropin ReceptorTransgenic MiceTransgenic Organismsautoreactive T cellbasecaspase-8designhuman SLC5A5 proteinin vivoleptin receptormacrophageprogramsprotective effecttranscription factor
项目摘要
Interferon gamma (IFNgamma) has been implicated in the pathogenesis of autoimmune (Hashimoto's) thyroiditis. We have generated transgenic mice that express IFNg specifically in the thyroid gland, and shown that IFNgamma a) directly induces primary hypothyroidism with decreased NIS expression; b) induces Hurthle cells-like and increase thyroidal fat; c) protects from autoimmune thyroiditis. Specific aim 1 is to test the hypothesis that the IFNg-driven activation of the immunoproteasome is critical to the ontogeny of Hurthle cells. We will: i) test whether pharmacologic or genetic blocks of the immunoproteasome inhibit the appearance of Hurthle cells; ii) evaluate in situ immunoproteasome expression in thyroids from thyr-IFNgamma transgenic mice, as well as from patients with Hurthle cell lesions. Specific aim 2 is to unravel the mechanism through which IFNgamma protects from autoimmune thyroiditis. We hypothesize that this protective effect is mediated by a caspase-8 dependent activation of apoptosis, which results in death of autoreactive, thyroid-specific lymphocytes. We will transduce autoreactive T cells with an inactive form of caspase-8 and adoptively transfer T cells to wild type or thyr-IFNgamma transgenic hosts, assessing thereafter the incidence and severity of thyroiditis. We wil also cross thyr-IFNgamma transgenics to knockout mice that lack IRF-1 or IRF-4, two critical transcription factors linking IFNgamma signaling with caspase-8 dependent apoptosis. Specific aim 3 is to study the interaction between IFNg interleukin-12 (IL-12) on thyroid autoimmunity and function. We have generated transgenic mice that express IL-12 specifically in the thyroid gland. The mice develop spontaneously lymphocytic thyroiditis and primary hypothyroidism with increased NIS expression. We will cross thyr-IL-12 transgenics to thyr-IFNg transgenics to assess whether the disease suppressive effect of IFNgamma prevails on the disease-promoting effect of IL-12, and whether IFNg and IL-12 synergistically induce a more severe form of hypothyroidism. Specific aim 4 is to investigate why thyroids from thyr-IFNg transgenic contain an increased number of adipocytes, and to assess whether this increase influences thyroid function. We hypothesize that thyroid macrophages primed in vivo by IFNg promote differentiation of stromal preadipocytes into mature adipocytes. We will co-culture thyroid macrophages from transgenics and controls with syngeneic pre-adipocytes, monitoring acquisition of morphological features typical of adipocytes. We also hypothesize that augmented TSH signaling is required to induce the adipocyte-rich phenotype, and cross thyr-IFNg transgenics to TSH receptor knockout mice.
干扰素γ (IFNgamma)与自身免疫性(桥本氏)甲状腺炎的发病机制有关。我们已经产生了在甲状腺中特异性表达IFNg的转基因小鼠,并表明IFNgamma a)直接诱导原发性甲状腺功能减退,并降低NIS的表达;b)诱导Hurthle细胞样细胞,增加甲状腺脂肪;C)预防自身免疫性甲状腺炎。具体目的1是验证ifng驱动的免疫蛋白酶体激活对Hurthle细胞的个体发生至关重要的假设。我们将:i)测试免疫蛋白酶体的药理学或遗传阻滞是否抑制Hurthle细胞的外观;ii)评估thyr-IFNgamma转基因小鼠和Hurthle细胞病变患者甲状腺中免疫蛋白酶体的原位表达。具体目的2是揭示IFNgamma保护自身免疫性甲状腺炎的机制。我们假设这种保护作用是由caspase-8依赖性的细胞凋亡激活介导的,细胞凋亡导致自身反应性甲状腺特异性淋巴细胞死亡。我们将用无活性的caspase-8转导自身反应性T细胞,并过继性地将T细胞转移到野生型或thyr-IFNgamma转基因宿主中,随后评估甲状腺炎的发病率和严重程度。我们还将交叉使用thyr-IFNgamma转基因基因敲除缺乏IRF-1或IRF-4的小鼠,IRF-1或IRF-4是连接IFNgamma信号与caspase-8依赖性凋亡的两个关键转录因子。具体目的3是研究IFNg白细胞介素-12 (IL-12)在甲状腺自身免疫和功能中的相互作用。我们已经产生了在甲状腺中特异性表达IL-12的转基因小鼠。小鼠出现自发性淋巴细胞性甲状腺炎和原发性甲状腺功能减退,并伴有NIS表达增加。我们将把thyr-IL-12转基因与thyr-IFNg转基因杂交,以评估IFNgamma的疾病抑制作用是否优于IL-12的疾病促进作用,以及IFNg和IL-12是否协同诱导更严重形式的甲状腺功能减退。具体目的4是研究为什么thyr-IFNg转基因的甲状腺含有更多的脂肪细胞,并评估这种增加是否影响甲状腺功能。我们假设IFNg在体内激活的甲状腺巨噬细胞促进基质前脂肪细胞向成熟脂肪细胞的分化。我们将转基因和对照的甲状腺巨噬细胞与同源前脂肪细胞共培养,监测脂肪细胞典型形态特征的获取。我们还假设需要增强的TSH信号来诱导富含脂肪细胞的表型,并将thyr-IFNg转基因到TSH受体敲除小鼠中。
项目成果
期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Studies on murine thyroiditis: new insights from organ flow cytometry.
小鼠甲状腺炎研究:器官流式细胞术的新见解。
- DOI:10.1089/105072503322021070
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Caturegli,Patrizio;Rose,NoelR;Kimura,Miho;Kimura,Hiroaki;Tzou,Shey-Cherng
- 通讯作者:Tzou,Shey-Cherng
Excess iodide decreases transcription of NIS and VEGF genes in rat FRTL-5 thyroid cells.
- DOI:10.1016/j.bbrc.2010.01.123
- 发表时间:2010-03-05
- 期刊:
- 影响因子:3.1
- 作者:Suzuki, Koichi;Kimura, Hiroaki;Wu, Huhehasi;Kudo, Naoko;Kim, Won Bae;Suzuki, Sayuri;Yoshida, Akio;Caturegli, Patrizio;Kohn, Leonard D.
- 通讯作者:Kohn, Leonard D.
Immunoproteasome overexpression underlies the pathogenesis of thyroid oncocytes and primary hypothyroidism: studies in humans and mice.
- DOI:10.1371/journal.pone.0007857
- 发表时间:2009-11-17
- 期刊:
- 影响因子:3.7
- 作者:Kimura HJ;Chen CY;Tzou SC;Rocchi R;Landek-Salgado MA;Suzuki K;Kimura M;Rose NR;Caturegli P
- 通讯作者:Caturegli P
Oncocytic mania: a review of oncocytic lesions throughout the body.
嗜酸细胞躁狂:对全身嗜酸细胞病变的回顾。
- DOI:10.1007/bf03347464
- 发表时间:2011
- 期刊:
- 影响因子:5.4
- 作者:Guaraldi,F;Zang,G;Dackiw,AP;Caturegli,P
- 通讯作者:Caturegli,P
Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model.
SJL 小鼠的自身免疫性垂体炎:来自新动物模型的临床见解。
- DOI:10.1210/en.2007-1692
- 发表时间:2008
- 期刊:
- 影响因子:4.8
- 作者:Tzou,Shey-Cherng;Lupi,Isabella;Landek,Melissa;Gutenberg,Angelika;Tzou,Ywh-Min;Kimura,Hiroaki;Pinna,Giovanni;Rose,NoelR;Caturegli,Patrizio
- 通讯作者:Caturegli,Patrizio
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PATRIZIO CATUREGLI其他文献
PATRIZIO CATUREGLI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PATRIZIO CATUREGLI', 18)}}的其他基金
A new serum test for the differential diagnosis of pituitary masses
鉴别诊断垂体肿块的新血清检测
- 批准号:
8017624 - 财政年份:2010
- 资助金额:
$ 27.21万 - 项目类别:
A new serum test for the differential diagnosis of pituitary masses
鉴别诊断垂体肿块的新血清检测
- 批准号:
7629887 - 财政年份:2009
- 资助金额:
$ 27.21万 - 项目类别:
A new serum test for the differential diagnosis of pituitary masses
鉴别诊断垂体肿块的新血清检测
- 批准号:
7842681 - 财政年份:2009
- 资助金额:
$ 27.21万 - 项目类别:
Advances in the pathogenesis of non-thyroidal illness
非甲状腺疾病发病机制的研究进展
- 批准号:
7554657 - 财政年份:2008
- 资助金额:
$ 27.21万 - 项目类别:
Advances in the pathogenesis of non-thyroidal illness
非甲状腺疾病发病机制的研究进展
- 批准号:
7360814 - 财政年份:2008
- 资助金额:
$ 27.21万 - 项目类别:
Interferon-gamma: its role in autoimmune thyroiditis and thyroid function
干扰素-γ:其在自身免疫性甲状腺炎和甲状腺功能中的作用
- 批准号:
7122047 - 财政年份:2000
- 资助金额:
$ 27.21万 - 项目类别:
Thyroidal Macrophages in Autoimmune Hypothyroidism and Hurthle Cells
自身免疫性甲状腺功能减退症中的甲状腺巨噬细胞和 Hurthle 细胞
- 批准号:
8145772 - 财政年份:2000
- 资助金额:
$ 27.21万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 27.21万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 27.21万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 27.21万 - 项目类别:
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 27.21万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 27.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 27.21万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 27.21万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 27.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 27.21万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 27.21万 - 项目类别:
Discovery Grants Program - Individual